Bio Pharma Dive
JANUARY 27, 2022
The site, which specializes in manufacturing off-the-shelf immunotherapies, was once a key asset for Atara. New owner Fujifilm will still supply the biotech under a long-term agreement.
pharmaphorum
JANUARY 27, 2022
Walter Greenleaf, PhD, neuroscientist and digital health expert at Stanford University’s Virtual Human Interaction Lab, tells us about the new book Applied Virtual Reality in Healthcare: Case Studies and Perspectives and why he and his co-authors gathered insights from some of the most prominent figures in the field of medical extended reality (XR).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 27, 2022
Backed by some of biotech's most powerful investors, Septerna is looking to usher in the next chapter of medicines that act on G protein-coupled receptors.
pharmaphorum
JANUARY 27, 2022
The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline and Alphabet’s Verily Life Sciences in 2016. A rheumatoid arthritis patient has become the first of five to be implanted with the wireless device in the UK study – using keyhole surgery at the NHS Greater Glasgow & Clyde Health Board in Scotland last November – in a first step towards treating chronic diseases by modifying nerve signals to organs in t
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
JANUARY 27, 2022
Stoffels, who helped build Galapagos in its early days, is now taking helm of the biotech as it looks to recover from a recent series of setbacks.
pharmaphorum
JANUARY 27, 2022
Akili Interactive has agreed a merger with special purpose acquisition company (SPAC) Social Capital Suvretta Holdings Corp I in a deal that will take it into public hands with a valuation of around $1 billion. The digital health company, which developed the first prescription gaming app to be approved by the FDA, will swell its coffers by more than $410 million gross once the deal go through.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
JANUARY 27, 2022
Prior to the COVID-19 pandemic, food trade shows helped small and large businesses alike attract new buyers and customers. In this episode of the Xtalks Food Podcast, Sydney talks about how food trade shows pivoted online during the ongoing pandemic and found success thanks to e-commerce. Since going digital, many food and beverage buyers have found it more convenient and saved money by attending online food trade shows.
Scienmag
JANUARY 27, 2022
CORVALLIS, Ore. – A new study found a steep decline in the development of forest and agricultural land from 2000 to 2015 compared to the previous two decades, which resulted in a broad shift towards denser development patterns throughout the U.S. A primary culprit was rising gas prices. Credit: Sean Nealon CORVALLIS, Ore. – A […].
Pharma Marketing Network
JANUARY 27, 2022
Tune in to the Pharma Marketing Network and industry experts Novartis, UCB, GSK and others, for a fireside talk on hot topics around what has changed in the last year and how to align your pharma marketing strategies accordingly. Three Panels: . Engaging Oncologists in 2022. Emerging Digital Channels and Navigating the Social Landscape: What’s Hot, What’s Not, What’s the Next Big Thing.
Scienmag
JANUARY 27, 2022
A unique instrument at Argonne’s Center for Nanoscale Materials combines a modified transmission electron microscope with an ultrafast laser system to reveal small details with potentially big impacts. Credit: (Image by Argonne National Laboratory.) A unique instrument at Argonne’s Center for Nanoscale Materials combines a modified transmission electron microscope with an ultrafast laser system to […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
JANUARY 27, 2022
MHRA awards a positive scientific opinion for voxelotor–a once-daily tablet for the treatment of haemolytic anaemia
Scienmag
JANUARY 27, 2022
A clinical trial has found that the combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, is not more effective than remdesivir alone for treating adults hospitalized with the disease. The trial also found that the safety of this experimental treatment may vary depending on whether […].
Pharma Times
JANUARY 27, 2022
Ground-breaking trial run by Oxford University has recruited 5000 people and will focus on severe COVID-19 symptoms
Scienmag
JANUARY 27, 2022
URBANA, Ill. – With water quality guidelines compelling more farmers to act on nitrogen loss, cover crops and split nitrogen applications are becoming more common in the Midwest. But new University of Illinois research shows these conservation practices may not provide environmental benefits across the board. Credit: University of Illinois URBANA, Ill. – With water […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
pharmaphorum
JANUARY 27, 2022
Biogen and Eisai have increased the earning potential of their Alzheimer’s drug Aduhelm by expanding the post-marketing trial of the drug required by the FDA – which could be the primary source of income for the drug. If the provisional reimbursement decision by the Centre for Medicare and Medicaid Services (CMS) is finalised, Aduhelm (aducanumab) will only be covered for certain patients enrolled in clinical trials.
Scienmag
JANUARY 27, 2022
Hyaluronic acid, or HA, is a known presence in pancreatic tumors, but a new study from researchers at the University of Michigan Health Rogel Cancer Center shows that hyaluronic acid also acts as food to the cancer cells. These findings, recently published in eLife, provide insight into how pancreatic cancer cells grow and indicate new […].
BioTech 365
JANUARY 27, 2022
Epizyme Announces Pricing of Public Offering of Common Stock Epizyme Announces Pricing of Public Offering of Common Stock CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc.
Scienmag
JANUARY 27, 2022
Humans have cooked with fire for millennia, but it may be time for a change. Natural gas appliances warm the planet in two ways: generating carbon dioxide by burning natural gas as a fuel and leaking unburned methane into the air. A new Stanford-led study reveals that the methane leaking from natural gas-burning stoves inside […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
JAMA Internal Medicine
JANUARY 27, 2022
This cohort study of US veterans hospitalized with COVID-19 with genetic information and with African ancestry through the VA Million Veteran Program to evaluates the association of APOL1 variations with.
Scienmag
JANUARY 27, 2022
For many, an ideal forest is one that looks the same as it did before European colonizers arrived. As today’s forests are hit with disturbances like fire, drought, and insect invasions, restoration efforts often attempt to nudge the landscape back to this ‘natural’ state. But historical conditions are becoming increasingly hard to achieve in a […].
pharmaphorum
JANUARY 27, 2022
Paul Stoffels’ retirement at the end of last year after nine years as head of R&D at Johnson & Johnson was short lived – he’s just been named chef executive of Galapagos. Stoffels will take the helm of the troubled Belgian biotech on 1 April, when Galapagos’ long-serving CEO and co-founder Onno van de Stolpe starts his own retirement after 22 years at the company.
Scienmag
JANUARY 27, 2022
Over one quarter of Europe’s 20 most highly-fished marine species will be under extreme pressure by 2100 if nothing is done to simultaneously halt climate change, overfishing, and mercury pollution, according to a new UBC study. Credit: Daderot Creative Commons CC0 1.0 Universal Public Domain Dedication. Over one quarter of Europe’s 20 most highly-fished marine […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Pharma Marketing Network
JANUARY 27, 2022
In partnership with Villanova University, Drexel University, Thomas Jefferson University, the University of the Sciences and Columbia Business School, the HBA continues to advocate for the connection between advanced education and advancement in the workplace. For Immediate Release: Philadelphia— January 18, 2022 — Today, the Mid-Atlantic Region and the Philadelphia Chapter of the Healthcare Businesswomen’s Association announced the curriculum for their Winter 2022 Master Class, a series of 5 on
Scienmag
JANUARY 27, 2022
A new study in mice from University of Maryland School of Medicine researchers showed that an unhealthy vaginal microbiome in pregnant mothers in combination with an unhealthy diet contributed to increased pup deaths and altered development in the surviving babies. The researchers offset these deaths from the unhealthy vaginal microbiome by giving the mothers a […].
BioPharma Reporter
JANUARY 27, 2022
Over the last 18 months, Aceto has made a series of manufacturing acquisitions, allowing it to better serve customers in biopharmaceutical, vaccine and pharmaceutical industries. It is now investing in several of its newly-acquired North American facilities: while keeping an eye out for further acquisition opportunities.
Scienmag
JANUARY 27, 2022
It’s difficult to plan ahead when SARS-CoV-2, the virus that causes COVID-19, is so unpredictable. But, there is now a straightforward method for predicting one of the resources needed to slow the spread of COVID-19 in communities. Researchers at Boston University (BU) developed a real-time method for projecting COVID-19 quarantine needs in congregate housing settings […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Patent Watch
JANUARY 27, 2022
Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…. The post New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA KIT appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 27, 2022
A few specialist microbes survive conditions analogous to those of Mars’ early history, reports a new publication in Frontiers in Astronomy and Space Science—and this may be thanks to a broad range of adaptations. The hydrothermal crater lake of the Poás volcano in Costa Rica is one of the most hostile habitats on the […].
Drug Patent Watch
JANUARY 27, 2022
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are thirty-one…. The post New patent expiration for Otsuka drug ABILIFY MYCITE KIT appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 27, 2022
The University of Surrey and Space Power are tackling the problem of powering satellites in Low Earth Orbit (LEO) during their eclipse period when they cannot see the sun. By collaborating on a space infrastructure project, the joint team will develop new technology which uses lasers to beam solar power from satellites under solar illumination […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
336 
Let's personalize your content